Volume 26, Number 8—August 2020
Dispatch
Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
Table 2
Case no. | Sexual orientation | Baseline test |
TOC after first-line therapy |
TOC after second-line therapy |
TOC after third-line therapy |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
parC | gyrA | parC | gyrA | parC | gyrA | parC | gyrA | |||||
1 | MSM | NA | NA | S83I | n/A | S83I | D99N | Cured | ||||
2 | MSM | S83I | M95I | S83I | M95I | S83I | M95I | Cured | ||||
3 | MSM | S83I | WT | S83I | WT | S83I | WT | Cured | ||||
4 | MSW | NA | NA | NA | NA | S83I | A79S | Cured | ||||
5 | MSW | D87N | WT | D87N | WT | D87N | WT | Cured | ||||
6 | MSW | NA | NA | S83I | WT | S83I | WT | Cured | ||||
7 | MSW | S83I | WT | S83I | WT | S83I | WT | Cured | ||||
8 | MSM | S83I | WT | S83I | WT | S83I | WT | Cured | ||||
9 | MSW | S83I | WT | S83I | WT | S83I | WT | S83I | WT | |||
10 | MSM | NA | NA | S83I | WT | S83I | WT | Cured | ||||
11 | W | S83I | WT | S83I | M95I | ND | ND | Cured | ||||
12 | W | S83I | M95I | S83I | M95I | S83I | M95I | Cured |
*MSM, men who have sex with men; MSW, men who have sex with women only; NA, sample was not available for sequencing; ND, not done; W, heterosexual woman; WT, wild type.
Page created: June 08, 2020
Page updated: July 18, 2020
Page reviewed: July 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.